These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 24346490
1. Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma. Motoyama T, Ogasawara S, Chiba T, Higashide T, Yokota H, Kanogawa N, Suzuki E, Ooka Y, Tawada A, Irie R, Ochi S, Masuda Y, Uno T, Yokosuka O. Abdom Imaging; 2014 Apr; 39(2):262-8. PubMed ID: 24346490 [Abstract] [Full Text] [Related]
2. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY. AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457 [Abstract] [Full Text] [Related]
11. Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma. Koda M, Tokunaga S, Okamoto T, Hodozuka M, Miyoshi K, Kishina M, Fujise Y, Kato J, Matono T, Sugihara T, Oyama K, Hosho K, Okano J, Murawaki Y, Kakite S, Yamashita E. J Hepatol; 2015 Dec; 63(6):1360-7. PubMed ID: 26232269 [Abstract] [Full Text] [Related]
13. Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images. Kim KW, Lee JM, Klotz E, Kim SJ, Kim SH, Kim JY, Han JK, Choi BI. AJR Am J Roentgenol; 2011 May; 196(5):W565-72. PubMed ID: 21512046 [Abstract] [Full Text] [Related]
14. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma. Long H, Zhou X, Zhang X, Ye J, Huang T, Cong L, Xie X, Huang G. Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191 [Abstract] [Full Text] [Related]
17. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma. Numata K, Fukuda H, Morimoto M, Kondo M, Nozaki A, Oshima T, Okada M, Takebayashi S, Maeda S, Tanaka K. Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088 [Abstract] [Full Text] [Related]
18. Detection of hepatocellular carcinoma in patients with cirrhosis: added value of coronal reformations from isotropic voxels with 64-MDCT. Marin D, Catalano C, De Filippis G, Di Martino M, Guerrisi A, Rossi M, Passariello R. AJR Am J Roentgenol; 2009 Jan; 192(1):180-7. PubMed ID: 19098199 [Abstract] [Full Text] [Related]
19. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma. Makino Y, Imai Y, Igura T, Hori M, Fukuda K, Sawai Y, Kogita S, Fujita N, Takehara T, Murakami T. Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767 [Abstract] [Full Text] [Related]